Reagent Grade Powder Anastrozole Intermediate

Anastrozole-inhibiting drug approved for treatment of breast cancer after surgery, as well as for metastasis in both pre and postmenopausal women. The severity of breast cancer is increased by estrogen, as hormones cause hyperplasia, and differentiation at estrogen receptor sites. It works by inhibiting the synthesis of estrogen.NAME OF PRODUCT : Anastrazole IntermediateCAS NO120511-73-1Structural FormulaC17H19N5Molecular Weight293.37AppearanceAn Off-White Color Crystalline PowderUseIt Can Be Used To The Treatment Of Breast Cancer About the Company GST Registration Date: 2017 Legal Status of Firm: Limited Company Number of Employees: 11 To 25 People Annual Turnover: 5 - 25 Cr company-description: Incorporated in the year 2007, under the visionary Mr. Sanjay Totre, today Yashica Pharmaceuticals has evolved as a pioneer in pharmaceutical drugs worldwide. The quality range of our products includes Active Pharmaceutical Ingredient (API) and Pharmaceutical Intermediates. These are manufactured as per the international standards & meet all regulation of pharmaceutical and chemical industries. With the help of our sound manufacturing facility, we are able to prepare a highly effective range of products. Our professional approach has helped us in maintaining the trust of our clients.